L. Webster, MD, R. Tummala, MD, MBA, MS, U. Diva, PhD, and J. Lappalainen, MD, PhD, “A 12-week extension study to assess the safety and tolerability of naloxegol in patients with noncancer pain and opioid-induced constipation”, J of Opioid Management, vol. 12, no. 6, pp. 405–419, Nov. 2016.